Pharmacists are often the first course of information when patients suffer oral problems. This article describes common oral conditions including dry mouth, their potential causes, and pharmacological and non-pharmacological treatments that may assist with the management of these conditions.
Low-dose methotrexate has been used for decades in the management of autoimmune conditions including rheumatoid arthritis. While long used orally as a once weekly dose, pharmacists are increasingly seeing methotrexate used weekly as a subcutaneous injection, administered by the patient or their carer. Pharmacists should be able to counsel patients on the mode of action, as well as both the oral and subcutaneous use, of this medication.
Building a compounding capability requires a solid understanding of the regulatory environment associated with compounding and allocating the appropriate resources to ensure compounded medicines meet with the same high standards of safety and efficacy that are required for registered commercially available medicines.